CRIS Q3 2021 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena

CRISCuris, Inc.

$14M

Q3 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M+10.8% YoY

Gross Profit

$3M95.0% margin

Operating Income

-$10M-330.6% margin

Net Income

-$11M-363.6% margin

EPS (Diluted)

$-2.41

QoQ Revenue Growth

+32.9%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$172M

Total Liabilities

$69M

Stockholders' Equity

$103M

Cash & Equivalents

$53M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$3M	+10.8%
Gross Profit	$3M	$3M	+10.8%
Operating Income	-$10M	-$5M	-113.3%
Net Income	-$11M	-$6M	-85.0%

Revenue Segments

Gross Royalty Revenue

$3M101%

Contra Revenue

-$19,000-1%